Eikon Therapeutics, Inc. - EIKN

All tracked SEC files for this issuer. Showing up to 200 latest records.
Need parsed ownership details (13D/13G with shares/percent)? Open ownership details
Form 4 = insider transactions report. Form 144 = notice of proposed sale (not a completed trade confirmation).

Files summary

Total files loaded: 15
Latest filed: Oct 26, 2026
Form Count
8-K 8
SCHEDULE 13G/A 3
SCHEDULE 13G 3
4 1

Latest files

Filed Form Report period Accession SEC
Oct 26, 2026 8-K Oct 26, 2026 0001193125-26-430860 View
Oct 23, 2026 8-K Oct 23, 2026 0001193125-26-429549 View
Oct 07, 2026 SCHEDULE 13G/A — 0000315066-26-002331 View
Oct 02, 2026 SCHEDULE 13G/A — 0001104659-26-113112 View
Sep 08, 2026 4 Sep 03, 2026 0001193125-26-385268 View
Aug 14, 2026 8-K Aug 13, 2026 0001193125-26-349936 View
Aug 13, 2026 8-K Aug 13, 2026 0001193125-26-349154 View
Aug 06, 2026 SCHEDULE 13G/A — 0000315066-26-001987 View
Aug 03, 2026 8-K Jul 31, 2026 0001193125-26-330710 View
Jun 10, 2026 8-K Jun 05, 2026 0001193125-26-265861 View
Jun 01, 2026 8-K May 30, 2026 0001193125-26-249725 View
May 15, 2026 SCHEDULE 13G — 0001720215-26-000006 View
May 13, 2026 SCHEDULE 13G — 0001193125-26-221988 View
May 11, 2026 8-K May 11, 2026 0001193125-26-216744 View
May 06, 2026 SCHEDULE 13G — 0000315066-26-001183 View